Gefilterte Suchergebnisse
R&D Systems™ Recombinant Human EGF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
|---|---|
| Rekombinant | Recombinant |
| Rekonstitution | Reconstitute at 500 μg/mL in sterile PBS. |
| Konjugat | Unconjugated |
| Zugriffsnummer | P01133 |
| Protein | EGF |
| Reinheits- oder Qualitätsgrad | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Name | EGF |
| Gensymbol | EGF |
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Molekulargewicht | M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Endotoxin-Konzentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Quelle | E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met |
| Gen-ID (Entrez) | 1950 |
R&D Systems™ Recombinant Mouse Galectin-3 (Hek293-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Human TNF-alpha Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate. |
|---|---|
| Molekulargewicht | M.W. Observed: 19-21 kDa, under reducing conditions., M.W. Theoretical: 19.2 kDa (monomer) |
| Rekonstitution | Reconstitute the 10 μg size at 100 μg/mL in sterile deionized water. Reconstitute all other sizes at 500 μg/mL in sterile deionized water. |
| Konjugat | Unconjugated |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Zugriffsnummer | NP_001165097.1 |
| Gen-Alias | MVCD1, VAS, vascular endothelial growth factor A, Vascular permeability factor, Vasculotropin, VEGFA, VEGF-A, VEGFMGC70609, VPF, VPFvascular endothelial growth factor |
| Protein | VEGF |
| Reinheits- oder Qualitätsgrad | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Gen-ID (Entrez) | 7422 |
R&D Systems™ Recombinant Human Cathepsin L Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity
R&D Systems™ Recombinant Human IL-6 Protein
A New rh IL-6 is Available! The new protein has ∼2 fold better activity and is HEK293 expressed!
| Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
|---|---|
| Rekombinant | Recombinant |
| Konjugat | Unconjugated |
| Zugriffsnummer | Q75MH2 |
| Protein | IL-6 |
| Reinheits- oder Qualitätsgrad | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Name | IL-6 |
| Gensymbol | IL6 |
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in PBS and NaCl. |
| Molekulargewicht | M.W. theroretical: 20.9 kDa |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Endotoxin-Konzentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Gen-Alias | B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A |
| Quelle | E. coli-derived human IL-6 protein Pro29-Met212 |
| Gen-ID (Entrez) | 3569 |
R&D Systems™ Recombinant Human IL-2 Protein
Contains the Cysteine to Serine substitution found in Proleukin™ (aldesleukin)
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate with Trehalose. |
|---|---|
| Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Molekulargewicht | M.W.-observed: 13 kDa, under reducing conditions., M.W.-theroretical: 15.5 kDa |
| Rekonstitution | Reconstitute the 10 μg size at 100 μg/mL in sterile deionized water. Reconstitute all other sizes (at 500 μg/mL in sterile deionized water.) |
| Konjugat | Unconjugated |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Zugriffsnummer | P60568.1 |
| Endotoxin-Konzentration | <0.01 EU / 1 μg of the protein by the LAL method. |
| Gen-Alias | aldesleukin, IL2, IL-2, IL-2 lymphokine, interleukin 2, interleukin-2, involved in regulation of T-cell clonal expansion, Proleukin, T cell growth factor, T-cell growth factor, TCGF |
| Quelle | E. coli-derived human IL-2 protein Ala21-Thr153 (Cys145Ser), with and without an N-terminal Met |
| Protein | IL-2 |
| Reinheits- oder Qualitätsgrad | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Gen-ID (Entrez) | 3558 |
R&D Systems™ Recombinant Human IL-10 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Human TNF-alpha, Biotinylated Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human Lymphotoxin alpha1/beta2 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Porcine TNF-alpha Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Viral Dengue Virus 2 NS1 Protein
R&D Systems™ Recombinant Viral Dengue Virus 2 NS1 Protein CF is a non-structural protein that is a viral glycoprotein.
R&D Systems™ Recombinant Human IL-10 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Kennzeichnung | RUO |
|---|---|
| Lagerungsbedingungen | Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution |
| Rekonstitution | Reconstitute at 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
| Konjugat | Unconjugated |
| Spezies | Human |
| Zugriffsnummer | P22301 |
| Reinheits- oder Qualitätsgrad | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Gensymbol | IL10 |
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Molekulargewicht | 18.6 kDa |
| Kreuzreaktivität | IL-10 |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Endotoxin-Konzentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Gen-Alias | CSIF, CSIFMGC126450, Cytokine synthesis inhibitory factor, GVHDS, IL10, IL10A, IL-10MGC126451, interleukin 10, interleukin-10, TGIF |
| Quelle | <EM>Spodoptera frμgiperda</EM>, <EM>Sf</EM> 21 (baculovirus)-derived human IL-10 protein Ser19-Asn178 |
| Gen-ID (Entrez) | 3586 |
R&D Systems™ Recombinant Human M-CSF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Kennzeichnung | RUO |
|---|---|
| Lagerungsbedingungen | Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution |
| Rekonstitution | Reconstitute at 50-500 μg/mL in sterile PBS. |
| Konjugat | Unconjugated |
| Spezies | Human |
| Zugriffsnummer | NP_757350 |
| Reinheits- oder Qualitätsgrad | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Gensymbol | CSF1 |
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Molekulargewicht | 18.5 kDa (monomer) |
| Kreuzreaktivität | M-CSF |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Endotoxin-Konzentration | <1.0 EU per 1 μg of the protein by the LAL method. |
| Quelle | <EM>E. coli</EM>-derived human M-CSF protein Glu33-Ser190, with an N-terminal Met |
| Gen-ID (Entrez) | 1435 |